METHOD FOR ASSAYING REG IV mRNA

• US 20070141595A1
• Filed: 10/12/2006
• Published: 06/21/2007
• Est. Priority Date: 10/28/2005
• Status: Abandoned Application

• Current Assignee: Tosoh Corporation
• Original Assignee: Tosoh Corporation
• Inventors: Hayashi, Toshinori, Saito, Juichi, Une, Kurando
• Application Number:
  US11/548,786
• Publication Number:
  US 20070141595A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6813 Hybridisation assays

Abstract

In an RNA amplification process comprising steps of using a first primer and a second primer, at least one of which has a promoter sequence at the 5′ end, and reverse transcriptase, to produce double-stranded DNA containing the promoter sequence, using the double-stranded DNA as template to produce an RNA transcript with RNA polymerase, and using the RNA transcript in turn as template for DNA synthesis with the reverse transcriptase to produce the double-stranded DNA, the amount of amplified RNA product is measured with an intercalating fluorescent dye-labeled nucleic acid probe.

Claims

1. A method for assaying Regenerating islet-derived family, member 4 (regenerating gene type 4) mRNA (Reg IV mRNA) present in a sample, the method being characterized by comprising

(1) a step of using a first primer homologous to at least a portion downstream from the 5′

end of a specified nucleotide sequence of said RNA and a second primer complementary to at least a portion upstream from the 3′

end of said specified nucleotide sequence, to produce double-stranded DNA containing a promoter sequence and said specified nucleotide sequence downstream from said promoter sequence, where at least one of said first and second primers has said promoter sequence at the 5′

end,

(2) a step of using said double-stranded DNA as template to produce an RNA transcript,

(3) a step of using said RNA transcript in turn as template for DNA synthesis, to amplify said RNA transcript in a chain-reaction, and

(4) a step of assaying the amount of said RNA transcript.

2. A method for assaying Reg IV mRNA according to claim 1, characterized by employing a combination of said first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO:

1 and said second primer which includes at least 15 bases of the sequence listed as SEQ ID NO;

2, a combination of said first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

3 and said second primer which includes at least 15 bases of the sequence listed as SEQ ID NO;

4, or a combination of said first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

5 and said second primer which includes at least 15 bases of the sequence listed as SEQ ID NO;

6.

3. A method for assaying Reg IV mRNA according to claim 1, characterized in that the assay of the amount of said RNA transcript is accomplished by measuring the change in the fluorescent property of a nucleic acid probe that is labeled with an intercalating dye and is designed so that when it forms a complementary double strand with the target nucleic acid, the intercalating fluorescent dye portion undergoes a change in fluorescent property by intercalating into said complementary double strand.

4. A method for assaying Reg IV mRNA according to claim 3, characterized by employing a combination of sequences of said first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO:

1, said second primer which includes at least 15 bases of the sequence listed as SEQ ID NO;

2 and the intercalating fluorescent dye-labeled nucleic acid probe which includes at least 15 bases of the sequence listed as SEQ ID NO;

7 or of the sequence complementary to said sequence, a combination of sequences of said first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

3, said second primer which includes at least 15 bases of the sequence listed as SEQ ID NO;

4 and the intercalating fluorescent dye-labeled nucleic acid probe which includes at least 15 bases of the sequence listed as SEQ ID NO;

8 or the sequence complementary to said sequence, or a combination of sequences of said first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

5, said second primer which includes at least 15 bases of the sequence listed as SEQ ID NO;

6 and the intercalating fluorescent dye-labeled nucleic acid probe which includes at least 15 bases of the sequence listed as SEQ ID NO;

9 or the sequence complementary to said sequence.

5. An assay reagent for Reg IV mRNA, characterized in that its essential constituent elements are oligonucleotides comprising a combination of sequences of a first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO:

1 and a second primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

2, where at least one of said first and second primers has a promoter sequence at the 5′

end, a combination of sequences of a first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

3 and a second primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

4, where at least one of said first and second primers has a promoter sequence at the 5′

end, or a combination of sequences of a first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

5 and a second primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

6, where at least one of said first and second primers has a promoter sequence at the 5′

end.

6. A method for assaying Reg IV mRNA, characterized in that its essential constituent elements are oligonucleotides comprising a combination of sequences of said first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO:

1, said second primer which includes at least 15 bases of the sequence listed as SEQ ID NO;

2 and the intercalating fluorescent dye-labeled nucleic acid probe which includes at least 15 bases of the sequence listed as SEQ ID NO;

7 or of the sequence complementary to said sequence, where at least one of said first and second primers has a promoter sequence at the 5′

end, a combination of sequences of said first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

3, said second primer which includes at least 15 bases of the sequence listed as SEQ ID NO;

4 and the intercalating fluorescent dye-labeled nucleic acid probe which includes at least 15 bases of the sequence listed as SEQ ID NO;

8 or of the sequence complementary to said sequence, where at least one of said first and second primers has a promoter sequence at the 5′

end, or a combination of sequences of said first primer which includes at least 15 contiguous bases of the sequence listed as SEQ ID NO;

5, said second primer which includes at least 15 bases of the sequence listed as SEQ ID NO;

6 and the intercalating fluorescent dye-labeled nucleic acid probe which includes at least 15 bases of the sequence listed as SEQ ID NO;

9 or of the sequence complementary to said sequence, where at least one of said first and second primers has a promoter sequence at the 5′

end.

7. An oligonucleotide for amplification or detection of Reg IV mRNA, comprising at least 15 contiguous bases of any of the nucleotide sequences listed as SEQ ID NOS:

1 to 9 or the sequences complementary to those sequences.